Programs recipients

Megan McNerney, MD, PhD - 2013 Young Investigator

Department of Pathology   ·   University of Chicago

“In Vivo Characterization of a Tumor Suppressor Associated with High-Risk Myeloid Neoplasms”

Awarded a $75,000 Cancer Research Foundation Young Investigator AwardMegan McNearny, MD, PhD

CUX1 is a transcription factor gene frequently inactivated in myeloid cancers and certain solid tumors. Myeloid cancers with loss of CUX1 are difficult to treat and carry a poor prognosis.

The proposed research will define the phenotypes and pathways in hematopoietic cells that are altered by CUX1 inactivation and may therefore identify new therapeutic targets that ultimately improve the outcome for patients with these diseases.

Watch Dr. McNerney present her Young Investigator Project

2015 Interim Report

2016 Final Report